Juno Therapeutics, Inc. Contracts & Agreements
90 Contracts & Agreements
- Business Finance (12 contracts)
- Business Operations (5)
- Human Resources (17)
- Intellectual Property (16)
- Mergers & Acquisitions (4)
- Real Estate (11)
- Uncategorized (25)
- Form of Performance Restricted Stock Unit Award Agreement under the 2014 Equity Incentive Plan (Filed With SEC on March 1, 2018)
- Offer Letter Agreement, dated November 8, 2017, by and between Ann Lee and the registrant (Filed With SEC on March 1, 2018)
- Fourth Amendment to Lease Agreement, effective November 29, 2017, by and between ARE-Seattle No. 16, LLC and the registrant (Filed With SEC on March 1, 2018)
- Fifth Amendment to Lease Agreement, effective November 29, 2017, by and between ARE-Seattle No. 16, LLC and the registrant (Filed With SEC on March 1, 2018)
- Letter Agreement, dated October 6, 2017, by and among Celgene Corporation, Celgene Switzerland LLC and the registrant (Filed With SEC on March 1, 2018)
- Form of Tax Reimbursement Agreement (Filed With SEC on February 1, 2018)
- Agreement and Plan of Merger, dated as of January 21, 2018, by and among Juno Therapeutics Inc., Celgene Corporation and Blue Magpie Corporation (Filed With SEC on January 22, 2018)
- Amendment No. 3 and Waiver of Fourth Amended and Restated Investors Rights Agreement, dated September 21, 2017 (Filed With SEC on November 1, 2017)
- Form of Performance Restricted Stock Agreement under the 2014 Equity Incentive Plan (Filed With SEC on October 20, 2017)
- Underwriting Agreement by and among Juno Therapeutics, Inc., Morgan Stanley & Co. LLC and J.P. Morgan Securities LLC, dated September 21, 2017 (Filed With SEC on September 22, 2017)
- Share Purchase Agreement and Omnibus Amendment by and between Juno Therapeutics, Inc., Celgene Corporation and certain of its affiliates, dated September 21, 2017 (Filed With SEC on September 22, 2017)
- Amendment No. 2 to Sponsored Research Agreement, effective March 31, 2017, by and between Seattle Childrens Hospital d/b/a Seattle Childrens Research Institute and the registrant (Filed With SEC on August 3, 2017)
- Amendment No. 3 to Sponsored Research Agreement, effective May 2, 2017, by and between Seattle Childrens Hospital d/b/a Seattle Childrens Research Institute and the registrant (Filed With SEC on August 3, 2017)
- Offer Letter Agreement, dated April 13, 2017, by and between Sunil Agarwal, M.D. and the registrant (Filed With SEC on August 3, 2017)
- First Amendment, dated February 15, 2017, to Sublease Agreement dated November 22, 2013, by and between Seattle Biomedical Research Institute and the registrant (Filed With SEC on May 4, 2017)
- First Amendment, dated February 11, 2015, to Sublease Agreement dated November 20, 2014, by and between Seattle Biomedical Research Institute and the registrant (Filed With SEC on May 4, 2017)
- Second Amendment, dated February 15, 2017, to Sublease Agreement dated November 20, 2014, by and between Seattle Biomedical Research Institute and the registrant (Filed With SEC on May 4, 2017)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on March 1, 2017)
- THIRD AMENDMENT TO LEASE AGREEMENT (Filed With SEC on March 1, 2017)
- JUNO THERAPEUTICS, INC. INDEPENDENT CONTRACTOR AGREEMENT (Filed With SEC on March 1, 2017)
- AMENDMENT TO AGREEMENT AND PLAN OF REORGANIZATION AGREEMENT AND ESCROW AGREEMENT (Filed With SEC on August 5, 2016)
- [Juno Letterhead] (Filed With SEC on August 5, 2016)
- LICENSE AGREEMENT byand among JUNO THERAPEUTICS, INC. and CELGENECORPORATION and CELGENE SWITZERLAND LLC Dated as of April 22, 2016 (Filed With SEC on August 5, 2016)
- AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 5, 2016)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on May 10, 2016)
- AMENDMENT NO. 1 TO AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on May 10, 2016)
- AMENDMENT NO. 2 to AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on May 10, 2016)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on May 10, 2016)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN STOCK GRANT AWARD AGREEMENT NOTICE OF GRANT OF STOCK AWARD (Filed With SEC on May 10, 2016)
- JUNO THERAPEUTICS, INC. SECOND AMENDMENT to FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on February 29, 2016)
- AMENDMENT NO. 2 TO COLLABORATION AGREEMENT (Filed With SEC on February 29, 2016)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 (Filed With SEC on February 29, 2016)
- JunoTherapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 (Filed With SEC on February 29, 2016)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on February 29, 2016)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT NOTICE OF STOCK OPTION GRANT (Filed With SEC on February 29, 2016)
- AMENDMENT NO. 1 TOEXCLUSIVE LICENSE AGREEMENT (Filed With SEC on February 29, 2016)
- JUNO THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION POLICY Adopted and approved December 7, 2015 (Filed With SEC on February 29, 2016)
- JUNO THERAPEUTICS, INC. CHANGE IN CONTROL AND SEVERANCE PLAN AND SUMMARY PLAN DESCRIPTION Effective as of November 4, 2015 (Filed With SEC on February 29, 2016)
- AGREEMENT AND PLAN OF REORGANIZATION by and among JUNO THERAPEUTICS,INC., P ACQUISITION CORPORATION, P ACQUISITION LLC, ABVITRO INC., FORTIS ADVISORS LLC, asSecurityholders... (Filed With SEC on January 11, 2016)
- SECOND AMENDMENT TO LEASE AGREEMENT (Filed With SEC on November 12, 2015)
- AMENDMENT AND WAIVER OF FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT OF JUNO THERAPEUTICS, INC. July 27, 2015 (Filed With SEC on August 14, 2015)
- AMENDMENT #2 TO LICENSE AGREEMENT ST. JUDE File No.: SF-03-0018 (Filed With SEC on August 14, 2015)
- NON-EXCLUSIVE SUBLICENSE AGREEMENT (Filed With SEC on August 14, 2015)
- FIRST AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 14, 2015)
- AMENDMENT NO. 2 to EXCLUSIVE LICENSEAGREEMENT (Filed With SEC on August 14, 2015)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 May 27, 2015 (Filed With SEC on August 14, 2015)
- SHARE PURCHASE AGREEMENT (Filed With SEC on June 29, 2015)
- VOTING AND STANDSTILL AGREEMENT (Filed With SEC on June 29, 2015)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 29, 2015)
- AGREEMENT AND PLAN OF MERGER by and among JUNO THERAPEUTICS,INC., X ACQUISITION CORPORATION, X-BODY, INC., Brant Binder, as Sellers Representative, and the Principal Stockholders... (Filed With SEC on June 5, 2015)
- 2015 Non-Employee Director Compensation Program (Filed With SEC on May 12, 2015)
- AMENDMENT NO. 1 TO SPONSORED RESEARCH AGREEMENT (Filed With SEC on May 12, 2015)
- SHARE PURCHASE AGREEMENT related to PROJECT SPYDER 1 TABLE OF CONTENTS (Filed With SEC on May 11, 2015)
- LEASE AGREEMENT (Filed With SEC on April 7, 2015)
- LEASE by and between BMR-217TH PLACE LLC, a Delaware limited liability company and JUNO THERAPEUTICS, INC., a Delaware corporation Table of Contents (Filed With SEC on February 9, 2015)
- MASTER CLINICAL STUDY AGREEMENT (Filed With SEC on December 16, 2014)
- Shares JUNO THERAPEUTICS, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT December 5, 2014 TABLE OF CONTENTS (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN RESTRICTED STOCK UNIT AWARD AGREEMENT NOTICE OF GRANT OF RESTRICTED STOCK UNITS (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. 2014 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT NOTICE OF STOCK OPTION GRANT (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on December 9, 2014)
- JUNO THERAPEUTICS, INC. EXECUTIVE INCENTIVE COMPENSATION PLAN Adopted by the Board of Directors on December 2, 2014 and effective immediately prior to the Companys initial public... (Filed With SEC on December 9, 2014)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on December 9, 2014)
- AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on November 24, 2014)
- AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on November 24, 2014)
- COLLABORATION AGREEMENT (Filed With SEC on November 24, 2014)
- Amendment No. 1 Collaboration Agreement (Filed With SEC on November 24, 2014)
- AMENDED AND RESTATED PATENT AND TECHNOLOGY LICENSE AGREEMENT (Filed With SEC on November 24, 2014)
- SUBLEASE AGREEMENT (Filed With SEC on November 24, 2014)
- JUNO THERAPEUTICS, INC. THIRD AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT August 1, 2014 TABLE OF CONTENTS (Filed With SEC on November 17, 2014)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 17, 2014)
- FC Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631 (Filed With SEC on November 17, 2014)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 17, 2014)
- AMENDMENT NO. 1 TO EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 17, 2014)
- MASTER SPONSORED RESEARCH AGREEMENT By and between MEMORIALSLOAN-KETTERING CANCER CENTER And Sponsor (Filed With SEC on November 17, 2014)
- MASTER CLINICAL STUDY AGREEMENT (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631 (Filed With SEC on November 17, 2014)
- EXCLUSIVE LICENSE AGREEMENT BETWEEN ST. JUDECHILDRENS RESEARCH HOSPITAL, INC. & JUNO THERAPEUTICS, INC. ST. JUDE File No.: SJ-03-0018 LICENSE AGREEMENT (Filed With SEC on November 17, 2014)
- EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 17, 2014)
- Amendment No. 1 to the ExclusiveLicense Agreement (Filed With SEC on November 17, 2014)
- SPONSORED RESEARCH AGREEMENT (Filed With SEC on November 17, 2014)
- FC Therapeutics, Inc. 8725 W. Higgins Road, Suite 290 Chicago, IL 60631 September 5, 2013 (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 January 1, 2014 (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 January 13, 2014 (Filed With SEC on November 17, 2014)
- Juno Therapeutics, Inc. 307 Westlake Avenue North, Suite 300 Seattle, WA 98109 March 20, 2014 (Filed With SEC on November 17, 2014)
- JUNO THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on November 17, 2014)
- JUNO THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN AS AMENDED AUGUST 1, 2014 (Filed With SEC on November 17, 2014)
- JUNO THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN RESTRICTED STOCK PURCHASE AGREEMENT (Filed With SEC on November 17, 2014)
- JUNO THERAPEUTICS, INC. 2013 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (Filed With SEC on November 17, 2014)